Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GEBBIA, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.387
EU - Europa 4.191
AS - Asia 3.812
SA - Sud America 658
Continente sconosciuto - Info sul continente non disponibili 543
AF - Africa 94
OC - Oceania 12
Totale 19.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.159
SG - Singapore 1.331
RU - Federazione Russa 1.143
IT - Italia 912
CN - Cina 873
BR - Brasile 507
HK - Hong Kong 430
VN - Vietnam 366
DE - Germania 334
UA - Ucraina 321
FI - Finlandia 293
PL - Polonia 272
GB - Regno Unito 247
BD - Bangladesh 244
FR - Francia 195
IE - Irlanda 178
JP - Giappone 131
SE - Svezia 108
CA - Canada 105
IN - India 88
KR - Corea 76
MX - Messico 53
TR - Turchia 49
AR - Argentina 48
IQ - Iraq 38
NL - Olanda 37
AT - Austria 32
CO - Colombia 28
RO - Romania 24
ZA - Sudafrica 23
EC - Ecuador 22
ES - Italia 20
UZ - Uzbekistan 18
BE - Belgio 17
ID - Indonesia 17
MY - Malesia 16
PK - Pakistan 16
JM - Giamaica 15
PH - Filippine 15
VE - Venezuela 14
MA - Marocco 13
AE - Emirati Arabi Uniti 12
CL - Cile 11
HN - Honduras 11
IR - Iran 11
AU - Australia 10
CR - Costa Rica 10
JO - Giordania 10
PY - Paraguay 10
SA - Arabia Saudita 10
KE - Kenya 9
TN - Tunisia 9
CI - Costa d'Avorio 8
EG - Egitto 8
GE - Georgia 8
GR - Grecia 8
UY - Uruguay 8
CH - Svizzera 7
NP - Nepal 7
SV - El Salvador 7
AL - Albania 6
DZ - Algeria 6
IL - Israele 6
LT - Lituania 6
BF - Burkina Faso 5
BG - Bulgaria 5
BO - Bolivia 5
EE - Estonia 5
ET - Etiopia 5
NI - Nicaragua 5
PS - Palestinian Territory 5
BH - Bahrain 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
KW - Kuwait 4
KZ - Kazakistan 4
OM - Oman 4
PE - Perù 4
AO - Angola 3
BB - Barbados 3
DK - Danimarca 3
EU - Europa 3
LB - Libano 3
PA - Panama 3
PR - Porto Rico 3
QA - Qatar 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CG - Congo 2
DM - Dominica 2
HU - Ungheria 2
LV - Lettonia 2
MN - Mongolia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
Totale 19.141
Salva come PNG Salva come JPEG
Città #
Ashburn 1.133
Fairfield 1.082
Singapore 901
San Jose 730
Woodbridge 565
Houston 511
Chandler 468
Seattle 425
Wilmington 415
Hong Kong 414
Cambridge 354
Ann Arbor 282
Moscow 243
Zgierz 224
Council Bluffs 203
Dublin 178
Jacksonville 173
Palermo 169
Beijing 158
Medford 155
Santa Clara 154
Los Angeles 148
Des Moines 126
Ho Chi Minh City 122
Tokyo 122
Altamura 117
Dallas 109
Frankfurt am Main 99
Princeton 98
Lauterbourg 97
New York 94
Lawrence 88
Nanjing 87
Chicago 82
Hefei 82
Hanoi 78
Helsinki 77
San Diego 71
Boardman 63
Buffalo 60
São Paulo 54
Dearborn 49
Milan 49
The Dalles 49
London 47
Tulsa 47
Columbus 37
Shenyang 35
Toronto 34
Rome 32
Warsaw 32
Atlanta 30
Denver 30
Hebei 29
Phoenix 28
Orem 27
Ludwigshafen am Rhein 25
Da Nang 24
Changsha 23
Nanchang 23
San Francisco 23
Brooklyn 22
Nuremberg 22
Rio de Janeiro 22
Saint Petersburg 21
Tianjin 20
Brasília 18
Guangzhou 18
Jinan 18
Amsterdam 17
Brussels 17
Montreal 17
Redwood City 17
Baghdad 16
Manchester 16
San Paolo di Civitate 16
Seongnam 16
Seoul 16
Jiaxing 15
Johannesburg 15
Mumbai 15
San Mateo 15
Zhengzhou 15
Izmir 14
Kumar 14
Paris 14
Philadelphia 14
Stockholm 14
Boston 13
Falls Church 13
Memphis 13
Naples 13
Tashkent 13
Vienna 13
Berlin 12
City of London 12
Ningbo 12
Springfield 12
Belo Horizonte 11
Charlotte 11
Totale 12.086
Salva come PNG Salva come JPEG
Nome #
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 376
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: A prospective study 376
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 370
Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit. 302
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor 287
Does pain intensity predict a poor opioid response in cancer patients? 284
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy 276
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale 271
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy 268
Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents 253
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial. 249
WHATSAPP MESSENGER AS A REAL-TIME TOOL FOR A LONG-DISTANCE ACTIVITY OF A MULTIDISCIPLINARY 247
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 234
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 233
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia. 232
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 223
Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. 219
ELF regimen in advanced gastrointestinal malignancies: An analysis of its clinical effectiveness and toxicity 217
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). 213
Anticancer oral therapy: Emerging related issues 212
Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience 211
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials 210
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106). 210
Breakthrough pain in oncology: a longitudinal study. 210
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases 210
A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma 210
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule 209
Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study. 203
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials. 202
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study 201
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5- Fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas 196
Oral vinorelbine may not induce acute pain at the tumor site. 194
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. 194
Combination chemotherapy of 5-Fluorouracil, Epidoxorubicin and Mitomicin C in the palliative treatment of locally-advanced and/or metastatic adenocarcinoma of the stomach. 194
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study 193
Oral versus intravenous vinorelbine: clinical safety profile 192
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial 191
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 190
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 187
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study. 186
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: A whatsapp messenger-based report from the Italian college of chief medical oncologists 186
Gastric metastasis from breast cancer 185
Treatment of advanced non-small cell lung cancer: chemotherapy with or without cisplatin? 184
A phase i-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma 184
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM) 180
Cetuximab in squamous cell head and neck carcinomas. 178
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 178
Liability of clinical oncologists and the COVID-19 emergency: Between hopes and concerns 178
Treatment of metastatic breast cancer with vinorelbine and docetaxel 178
Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials 177
Latissimus Dorsi Flap and Thoracodorsal Artery Perforator Flap with Immediate Fat Transfer (LIFT and TIFT): A Retrospective Study about Total Breast Reconstruction in High-Risk Patients 176
Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer 175
Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.) 171
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 Study 171
Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma 169
Italian clinical research in non-small-cell lung cancer 169
“Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium” 168
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. 168
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer 167
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 159
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial 158
Ondasetron versus granisetron in the prevention of chemotherapy‐induced nausea and vomiting. Results of a prospective randomized trial 158
Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel 156
Virtual clinical and precision medicine tumor boards-cloud-based platform-mediated implementation of multidisciplinary reviews among oncology centers in the covid-19 era: Protocol for an observational study 156
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale 155
Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas 154
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. 153
Cetuximab: clinical results in colorectal cancer. 152
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 152
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience 152
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma 151
MISURARE LA FRAGILITÀ DEL PAZIENTE ONCOLOGICO ANZIANO 151
Subcutaneous recombinant human erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer. 151
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 150
Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management. 149
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 149
Opioid plasma concentration during switching from morphine to methadone: Preliminary data 146
UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 145
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer 143
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 139
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 138
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World 138
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 136
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer 132
Safety and efficacy of the treatment with Nab-paclitaxel in mEtastatic bREast cancer In elDerly patiEnts: NEREIDE study 132
Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with gluthatione protection in patients with advanced head and neck cancer 131
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma 126
Short term intensive preoperative chemotherapy with high doses of epirubicin plus G-CSF rescue for locally advanced Stage III breast carcinoma. 126
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety 124
Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM) 120
GEMCITABINE AND CISPLATIN FOR INOPERABLE AND/OR METASTATIC BILIARY TREE CARCINOMAS: A MULTICENTER PHASE II STUDY OF THE GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE (GOIM) 120
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care 119
Mitoxantrone + Prednisone versus Taxotere + Prednisone nel trattamento del carcinoma prostatico ormonorefrattario (cpor ). Studio randomizzato di fase II del Gruppo Oncologico dell’Italia Meridionale (GOIM ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 116
Vinorelbine plus cisplatinum for the treatment of Stage IIIB and IV Non Small Cell Lung Carcinoma. 113
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 113
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes 113
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 113
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 112
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 109
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma? 107
Totale 18.294
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.566
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022844 0 0 0 62 58 42 69 57 145 149 62 200
2022/20231.411 134 321 27 126 162 232 91 80 136 12 46 44
2023/2024602 29 97 67 48 37 92 46 27 12 15 40 92
2024/20251.874 50 166 183 144 96 60 130 109 124 194 202 416
2025/20266.767 428 231 401 445 687 931 882 686 545 778 344 409
2026/20271.798 479 391 778 150 0 0 0 0 0 0 0 0
Totale 19.697